torrent

  1. Torrent Power arm to set up solar projects to supply power to ARS Steels

    Torrent Power arm to set up solar projects to supply power to ARS Steels

    New Delhi: Torrent Power subsidiary Torrent Energy 14 (TU14) will set up solar projects of up to 50 MW to supply clean power to ARS Steels & Alloys International (ARS), it said in a BSE filing on Monday.According to the Membership and Shareholder Agreement (SSSA) signed on Monday, ARS will...
  2. USFDA issues Form 483 with five comments to Torrent Pharma entity

    USFDA issues Form 483 with five comments to Torrent Pharma entity

    New Delhi: Torrent Pharmaceuticals on Wednesday said the US health regulator has issued a Form 483 with five observations after inspecting its Gujarat-based manufacturing plant.The US Food and Drug Administration (USFDA) conducted pre-approval inspection (PAI) and GMP inspection at the...
  3. Torrent Group's m-cap doubles to $20 billion in one year

    Torrent Group's m-cap doubles to $20 billion in one year

    MUMBAI: Diversified Torrent Group on Friday crossed US$20 billion (Rs 1.68 lakh crore) in market capitalisation, almost doubling its market value due to strong growth in businesses spanning from pharma to energy.Torrent Group's m-cap as on 6 June 2023 was US$10.8 billion (Rs 90,230 crore).On...
  4. Torrent Pharma signs licensing agreement with Takeda to commercialize GERD drug

    Torrent Pharma signs licensing agreement with Takeda to commercialize GERD drug

    New Delhi, Torrent Pharmaceuticals on Wednesday said it has entered into a non-exclusive patent licensing agreement with Takeda to commercialize vonoprazan in India.Vonoprozan is a novel potassium-competitive acid inhibitor (P-CAB), used for the treatment of the acid-related disorders...
  5. Torrent Pharma signs licensing agreement with Takeda to commercialize GERD drug

    Torrent Pharma signs licensing agreement with Takeda to commercialize GERD drug

    New Delhi, Torrent Pharmaceuticals on Wednesday said it has entered into a non-exclusive patent licensing agreement with Takeda to commercialize vonoprazan in India.Vonoprozan is a novel potassium-competitive acid inhibitor (P-CAB), used for the treatment of the acid-related disorders...
  6. Torrent Pharma Q4 profit rises 56.45 percent to Rs 449 crore

    Torrent Pharma Q4 profit rises 56.45 percent to Rs 449 crore

    New Delhi, Torrent Pharmaceuticals Ltd on Friday reported 56.45 per cent rise in March quarter consolidated net profit to Rs 449 crore on the back of higher revenue.Torrent Pharmaceuticals said in a regulatory filing that the company had posted a consolidated net profit of Rs 287 crore in the...
  7. Torrent Power's net profit falls 8 percent to Rs 447 crore in March quarter

    Torrent Power's net profit falls 8 percent to Rs 447 crore in March quarter

    New Delhi: Torrent Power on Wednesday said its consolidated net profit declined 7.6 per cent to Rs 447 crore in the March 2024 quarter mainly due to higher expenses.The company had reported a consolidated net profit of Rs 484 crore for the quarter ending March 2023, BSE filings showed.Total...
Back
Top